Kina steroider pulver / GBL / Peptider / HGH
bucky@pharm-chemicals.com +8613237122310
EnglishFrançaisDeutschLatīnaپارسیPortuguêsРусскийEspañolSvenskaTürkçe
 Redigera översättning

Kina

» Tags » China

LGD-3303 CAS:917891-35-1

LGD-3303 CAS:917891-35-1

LGD-3303 som LG121071, utvecklades av Ligand Pharmaceuticals. Den kemiska strukturen hos LGD-3303 liknar den hos LGD-4033, en annan SARM utvecklad av Ligand Pharmaceuticals.LGD 3303 är INTE Anamorelin. Det är den mest potenta SARM vi har sett personligen hittills! LGD 3303 – De flesta anabola SARM-pulver? Det har varit mycket förvirring om LGD 3303 being the growth hormone

LGD-4033 CAS:1165910-22-4

LGD-4033 CAS:1165910-22-4

LGD-4033 (Ligandrol) is a novel non-steroidal oral SARM that binds to AR with high affinity (Ki of ~1 nM) and selectivity. It’s in a class of androgen receptor (AR) ligands that is tissue selective, developed to treat muscle wasting associated with cancer, acute and chronic illness and age-related muscle loss. LGD-4033 (Ligandrol) is expected to produce the therapeutic benefits of

YK11 CAS:1370003-76-1

YK11 CAS:1370003-76-1

Descriptions about YK11 YK-11 is a synthetic, steroidal selective androgen receptor modulator (SARM). It is a gene-selective partial agonist of the androgen receptor (AR) and does not induce the physical interaction between the NTD/AF1 and LBD/AF2 (known as the N/C interaction), which is required for full transactivation of the AR. The drug has anabolic activity in vitro in C2C12 myoblasts

RAD-140 CAS:1182367-47-0

RAD-140 CAS:1182367-47-0

RAD140 (Testolone) Description: RAD140 is a highly effective, oral SARM currently being studied for both anabolic and neuroprotective effects. It is in a class of androgen receptor (AR) ligands that are tissue selective, developed to treat muscle wasting associated with cancer, acute and chronic illness and age-related muscle loss. Recent research of RAD140 shows superior lean tissue selectivity, and reduced

GW-0742 CAS:317318-84-6

GW-0742 CAS:317318-84-6

GW0742 är en mycket selektiv och potent PPAR deltaagonist. Den säljs för närvarande för forskningsändamål under en licens från GlaxoSmithKline. PPAR delta-agonister är nukleära receptorproteiner som spelar avgörande roller för att reglera mänsklig metabolism, cellutveckling, och celldifferentiering. Produktens funktion minskar tarminflammation Förbättrar hjärthälsa Hjälper till med diabetes Förbättrar lipidprofilen Förhindrar högt blodtryck

GW-501516 CAS:317318-70-0

GW-501516 CAS:317318-70-0

Basic Information about Cardarine Endurobol GW-501516 GW501516 (also known as GW-501,516, GW1516, GSK-516 and Endurobol, is a PPARδ receptor agonist that was invented in a collaboration between Ligand Pharmaceuticals and GlaxoSmithKline in the 1990s, was entered into clinical development as a drug candidate for metabolic diseases and cardiovascular diseases, and was abandoned in 2007 because animal testing showed that the

SR9011 CAS:1379686-29-9

SR9011 CAS:1379686-29-9

SR9011 is a potent and specific synthetic REV-ERB agonist that binds to REV-ERB-α with an EC50 ~790 nM and REV-ERB-β with EC50 ~560 nM. It also has good in vivo plasma/brain exposure. The nuclear receptors REV-ERB-α and REV-ERB-β play an integral role in regulating the expression of core clock proteins, driving rhythms in activity and metabolism. Administration of SR9011 alters

SR9009 CAS:1379686-30-2

SR9009 CAS:1379686-30-2

SR9009 Benefits Promotes the healing of ligaments, tendons, bones as well as old injuries Stimulates loose skin to tighten Promotes lean muscle mass Increases the oxidation of fat SR9009: A Drug That Might Cause A Major Breakthrough in Fitness The drug was developed by Professor Thomas Burris who found that it was capable of reducing obesity in animal models, particularly

MK-1775 CAS:955365-80-7

MK-1775 CAS:955365-80-7

What is MK-1775? MK-1775 is an inhibitor of the checkpoint kinase Wee1 (IC50 = 5.2 nM).1 It has been shown to inhibit the phosphorylation of Cdc2 at tryosine-15, which abrogates the G2 DNA damage checkpoint.1 In p53-deficient tumors that rely solely on the G2 checkpoint upon DNA damage, MK-1775, in combination with DNA-damaging chemotherapeutic agents, is reported to induce apoptosis

MK-2866 CAS:841205-47-8

MK-2866 CAS:841205-47-8

Enobosarm, better known as Ostarine or MK 2866, is a Selective Androgen Receptor Modulator (SARM) developed by GTx (GTx-024) to combat muscle wasting and osteoporosis. Many speculate Ostarine may find uses in hormone replacement treatment plans, as well as in the treatment of sarcopenia, cachexia and muscle atrophy. This is a highly valuable benefit to those suffering from muscle wasting

MK-677 CAS:159752-10-0

MK-677 CAS:159752-10-0

MK 677 (IbutaMoren ) is rather similar to peptides like Ipamorelin and GHRP-6, but is administered orally and unlikely to set off the side effects that the latter can possibly cause during use. Apart from ease of use since you don’t have to do painful and inconvenient injections with MK 677 (IbutaMoren ), you can also expect to have significant

Androstenedione CAS:63-05-8

Androstenedione CAS:63-05-8

Androstenedione is the common precursor of male and female sex hormones. Some androstenedione is also secreted into the plasma, and may be converted in peripheral tissues to testosterone and estrogens. Androstenedione can be synthesized in one of two ways. The primary pathway involves conversion of 17-hydroxypregnenolone to dehydroepiandrosterone by way of 17,20-lyase, with subsequent conversion ofdehydroepiandrosterone to androstenedione via the

  • Vår fördel

    Hög kvalitet

    Bra pris

    Garanti leverans

    Bästa servicen

    100% Pengar tillbaka

  • huvudprodukter

    GBL

    BDO

    Trenbolone A/E

    Testosteron E/P

    HGH/HCG/IGF

  • Betalningsvillkor

    Bitcoin

    Banköverföring

    Western Union

    Penga gram

  • Kontakta oss

    E-post: bucky@pharm-chemicals.com

    WhatsApp: +8613237122310

    www.china-steroids-powder.com